When Patients Move Faster Than Peer Review
Patient communities are doing rigorous research work that the medical publication system, by necessity, cannot match for speed. We are not complaining about peer review. We are offering a patient-grounded solution for medical affairs and publications teams to find evidentiary gaps faster and to utilize partners best positioned to close them.
Peer review is necessarily slow. Careful evidentiary standards take time. However, even the best evidentiary standards cannot solve the problem of a foundational clinical model that itself is wrong–not merely incomplete, but mischaracterized at the level of disease definition.
This is plainly seen in Sjögren's disease, our working example:
Terminology that the international research community formally retired years ago still appears in current CME programs, scholarly presentations, and papers.
Validated instruments routinely used to measure systemic disease activity exclude the systemic features patients consistently identify as most disabling.
Prevalence estimates derive from studies that count only patients diagnosed using those criteria. This vastly understates the burden of organ involvement–and vastly underestimates the actual number of patients.
Those underestimates propagate forward through citation chains into clinical heuristics, educational programs, and the assumptions clinicians bring into the exam room.
The literature serving as the basis for treatment is sitting on a badly-flawed foundation. The patients living with the condition are suffering because of it.
What our community is doing instead is rigorous, and it deserves to be seen as such. Our members track weekly literature feeds. They verify citations against PubMed to guard against hallucinated sources. They maintain personally curated libraries organized across more than a hundred topics. They critique study designs at the level of inclusion criteria and assessment instruments, and they identify methodological errors that produce systematically skewed prevalence estimates. Some have spent years synthesizing the literature and presenting it publicly to clinicians, putting them ahead of most practitioners on the current state of the evidence. A recent three-day Ask the Expert session with our Sjögren's community and Erika Warren of Inciteful Med made the practice visible in real time. (Warren's own account of the conversation is worth reading for the texture of what serious patient research practice looks like.)
This is the same kind of patient knowledge work increasingly recognized in the peer-reviewed literature itself, from PCORI's formal methods for patient-engaged research and the FDA's guidance on incorporating patient experience data into drug development to the growing body of work in journals such as BMJ, Health Expectations, and Research Involvement and Engagement that documents how patient communities reshape research priorities, classification criteria, and clinical guidelines.
We see a substantial opportunity for medical affairs and publications teams to treat this work as a formal input. Smart Patients is built to make it systematic. We uncover gaps by working with our patient communities to analyze the questions they are raising, the patterns they are seeing, and the points where lived experience diverges from–or is not recognized in–the published literature. We map what is known against what our communities are experiencing, working alongside partners like Inciteful Med to triangulate against the evidence base and identify the questions that have not yet been studied. And we help close those gaps by routing patient-grounded questions back into research priority-setting, protocol design, and pre- and post-publication review—the upstream points in the pipeline where patient input can change what gets studied, how it is studied, and what gets understood from it.
The peer-reviewed research will get there eventually, rebuilding faulty foundational thinking to reflect current understandings. In the meantime, mischaracterized patients whose conditions are desperate and deteriorating cannot wait for the publication cycle.
We see that the medical affairs and publications teams making the strongest contributions to their fields are already finding ways to learn from patient communities. Casting the net wider is not a softening of evidentiary standards. It is a recognition that patients are finding the gaps the existing pipeline cannot find fast enough on its own.
Sources
Sheridan S, Schrandt S, Forsythe L, Hilliard TS, Paez KA. Advisory Panel on Patient Engagement (2013 inaugural panel). The PCORI Engagement Rubric: Promising Practices for Partnering in Research. Ann Fam Med. 2017;15(2):165-170. doi:10.1370/afm.2042
Staniszewska S, Denegri S, Matthews R, et al. Reviewing progress in public involvement in NIHR research: developing and implementing a new vision for the future. BMJ Open 2018;8:e017124. doi:10.1136/ bmjopen-2017-017124
FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient’s Voice in Medical Product Development and Regulatory Decision Making.(current content as of 10/23/2025) https://www.fda.gov/drugs/development-approval-process-drugs/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical